BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16538057)

  • 1. Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods.
    Kim MJ; Kim KR; Ro JY; Lage JM; Lee HI
    Am J Surg Pathol; 2006 Mar; 30(3):362-9. PubMed ID: 16538057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
    Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
    Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective pericyte recruitment of villous stromal vessels as the possible etiologic cause of hydropic change in complete hydatidiform mole.
    Kim KR; Sung CO; Kwon TJ; Lee J; Robboy SJ
    PLoS One; 2015; 10(4):e0122266. PubMed ID: 25849742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole.
    Cheville JC; Robinson R; Benda JA
    Pediatr Pathol Lab Med; 1996; 16(1):41-50. PubMed ID: 8963630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis contributes to vascular lumen formation and vascular branching in human placental vasculogenesis.
    Tertemiz F; Kayisli UA; Arici A; Demir R
    Biol Reprod; 2005 Mar; 72(3):727-35. PubMed ID: 15564598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
    Dong Y; Zhang S; Wang ML; Guo H; Zhang Y; Wang Y; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):194-8. PubMed ID: 21503111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
    Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascularization and expression of angiogenic factors in partial and complete molar pregnancies.
    Nagymanyoki Z; Growdon WB; Sarno J; Callahan MJ; Parast MM; Fulop V; Mok SC; Horowitz N; Berkowitz RS
    J Reprod Med; 2008 Aug; 53(8):589-94. PubMed ID: 18773623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic and immunohistochemical evaluation of blood vessels in complete and partial hydatidiform mole.
    Dickson-González SM; García de Barriola V; Barbella-Aponte RA; Figueira L; Cortés-Charry R; Naranjo de Gómez M
    J Reprod Med; 2006 Dec; 51(12):933-7. PubMed ID: 17253040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past.
    Mosher R; Goldstein DP; Berkowitz R; Bernstein M; Genest DR
    J Reprod Med; 1998 Jan; 43(1):21-7. PubMed ID: 9475145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole.
    Thaker HM; Berlin A; Tycko B; Goldstein DP; Berkowitz RS; Castrillon DH; Genest DR
    J Reprod Med; 2004 Aug; 49(8):630-6. PubMed ID: 15457853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the vascular profile and CD99 protein expression in the partial and complete hydatidiform moles using quantitative CD34 immunohistochemistry.
    Hussein MR
    Exp Mol Pathol; 2010 Dec; 89(3):343-50. PubMed ID: 20630481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerous vessels detected by CD34 in the villous stroma of complete hydatidiform moles.
    Qiao S; Nagasaka T; Nakashima N
    Int J Gynecol Pathol; 1997 Jul; 16(3):233-8. PubMed ID: 9421088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
    Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
    Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical localization of chorionic gonadotropin, placental lactogen, and placental alkaline phosphatase in the diagnosis of complete and partial hydatidiform moles.
    Brescia RJ; Kurman RJ; Main CS; Surti U; Szulman AE
    Int J Gynecol Pathol; 1987; 6(3):213-29. PubMed ID: 3429106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very early complete hydatidiform mole.
    Keep D; Zaragoza MV; Hassold T; Redline RW
    Hum Pathol; 1996 Jul; 27(7):708-13. PubMed ID: 8698316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculogenesis in complete and partial hydatidiform mole pregnancies studied with CD34 immunohistochemistry.
    Lisman BA; Boer K; Bleker OP; van Wely M; Exalto N
    Hum Reprod; 2005 Aug; 20(8):2334-9. PubMed ID: 15878926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of first trimester human fetal placental vessels using immunocytochemical markers.
    Challier JC; Carbillon L; Kacemi A; Vervelle C; Bintein T; Galtier M; Espié MJ; Uzan S
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL79-87. PubMed ID: 11936878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.